What is Biotechnology Solutions?
Biotechnology Solutions operates as a specialized provider of bacterial growth media, catering primarily to the rigorous demands of the oil and gas industry. By delivering essential biological testing materials, including DIP slide tests and advanced microbiological identification solutions, the company serves as a vital link in the industrial quality control supply chain. Beyond its core product offerings, the firm distinguishes itself through contract manufacturing and custom media development, ensuring that clients maintain strict compliance with evolving industry standards. This dual-focus on standardized supply and bespoke manufacturing positions the company as a critical partner for energy firms requiring rapid, reliable diagnostic capabilities.
How much funding has Biotechnology Solutions raised?
Biotechnology Solutions has raised a total of $133K across 1 funding round:
Debt
$133K
Debt (2021): $133K with participation from PPP
Key Investors in Biotechnology Solutions
PPP
Public-Private Partnership
What's next for Biotechnology Solutions?
With the influx of $133K, Biotechnology Solutions is poised to accelerate its market penetration and operational capacity. The company is expected to leverage this capital to enhance its contract manufacturing infrastructure, potentially expanding its footprint into adjacent industrial sectors that require high-throughput microbiological testing. As the firm transitions through this late-stage growth phase, strategic priorities will likely include optimizing supply chain resilience and investing in R&D to refine its custom media solutions. By maintaining its commitment to quality control and regulatory compliance, the organization is well-equipped to solidify its leadership in the niche market of industrial biological diagnostics, providing a stable foundation for long-term value creation in the energy and environmental testing landscape.
See full Biotechnology Solutions company page
